These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 33609457)

  • 1. BCG-induced non-specific effects on heterologous infectious disease in Ugandan neonates: an investigator-blind randomised controlled trial.
    Prentice S; Nassanga B; Webb EL; Akello F; Kiwudhu F; Akurut H; Elliott AM; Arts RJW; Netea MG; Dockrell HM; Cose S;
    Lancet Infect Dis; 2021 Jul; 21(7):993-1003. PubMed ID: 33609457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Live-attenuated Mycobacterium tuberculosis vaccine MTBVAC versus BCG in adults and neonates: a randomised controlled, double-blind dose-escalation trial.
    Tameris M; Mearns H; Penn-Nicholson A; Gregg Y; Bilek N; Mabwe S; Geldenhuys H; Shenje J; Luabeya AKK; Murillo I; Doce J; Aguilo N; Marinova D; Puentes E; Rodríguez E; Gonzalo-Asensio J; Fritzell B; Thole J; Martin C; Scriba TJ; Hatherill M;
    Lancet Respir Med; 2019 Sep; 7(9):757-770. PubMed ID: 31416768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigating the non-specific effects of BCG vaccination on the innate immune system in Ugandan neonates: study protocol for a randomised controlled trial.
    Prentice S; Webb EL; Dockrell HM; Kaleebu P; Elliott AM; Cose S
    Trials; 2015 Apr; 16():149. PubMed ID: 25872925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and immunogenicity of ChAdOx1 85A prime followed by MVA85A boost compared with BCG revaccination among Ugandan adolescents who received BCG at birth: a randomised, open-label trial.
    Wajja A; Nassanga B; Natukunda A; Serubanja J; Tumusiime J; Akurut H; Oduru G; Nassuuna J; Kabagenyi J; Morrison H; Scott H; Doherty RP; Marshall JL; Puig IC; Cose S; Kaleebu P; Webb EL; Satti I; McShane H; Elliott AM;
    Lancet Infect Dis; 2024 Mar; 24(3):285-296. PubMed ID: 38012890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and immunogenicity of VPM1002 versus BCG in South African newborn babies: a randomised, phase 2 non-inferiority double-blind controlled trial.
    Cotton MF; Madhi SA; Luabeya AK; Tameris M; Hesseling AC; Shenje J; Schoeman E; Hatherill M; Desai S; Kapse D; Brückner S; Koen A; Jose L; Moultrie A; Bhikha S; Walzl G; Gutschmidt A; Kotze LA; Allies DL; Loxton AG; Shaligram U; Abraham M; Johnstone H; Grode L; Kaufmann SHE; Kulkarni PS
    Lancet Infect Dis; 2022 Oct; 22(10):1472-1483. PubMed ID: 35772447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BCG revaccination of health workers in Brazil to improve innate immune responses against COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Junqueira-Kipnis AP; Dos Anjos LRB; Barbosa LCS; da Costa AC; Borges KCM; Cardoso ADRO; Ribeiro KM; Rosa SBA; Souza CC; das Neves RC; Saraiva G; da Silva SM; Silveira EA; Rabahi MF; Conte MB; Kipnis A
    Trials; 2020 Oct; 21(1):881. PubMed ID: 33106170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using BCG vaccine to enhance non-specific protection of health care workers during the COVID-19 pandemic: A structured summary of a study protocol for a randomised controlled trial in Denmark.
    Madsen AMR; Schaltz-Buchholzer F; Benfield T; Bjerregaard-Andersen M; Dalgaard LS; Dam C; Ditlev SB; Faizi G; Johansen IS; Kofoed PE; Kristensen GS; Loekkegaard ECL; Mogensen CB; Mohamed L; Ostenfeld A; Oedegaard ES; Soerensen MK; Wejse C; Jensen AKG; Nielsen S; Krause TG; Netea MG; Aaby P; Benn CS
    Trials; 2020 Sep; 21(1):799. PubMed ID: 32943115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early versus late BCG vaccination in HIV-1-exposed infants in Uganda: study protocol for a randomized controlled trial.
    Nankabirwa V; Tumwine JK; Namugga O; Tylleskär T; Ndeezi G; Robberstad B; Netea MG; Sommerfelt H
    Trials; 2017 Mar; 18(1):152. PubMed ID: 28359325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of lactoferrin supplementation on death or major morbidity in very low birthweight infants (LIFT): a multicentre, double-blind, randomised controlled trial.
    Tarnow-Mordi WO; Abdel-Latif ME; Martin A; Pammi M; Robledo K; Manzoni P; Osborn D; Lui K; Keech A; Hague W; Ghadge A; Travadi J; Brown R; Darlow BA; Liley H; Pritchard M; Kochar A; Isaacs D; Gordon A; Askie L; Cruz M; Schindler T; Dixon K; Deshpande G; Tracy M; Schofield D; Austin N; Sinn J; Simes RJ;
    Lancet Child Adolesc Health; 2020 Jun; 4(6):444-454. PubMed ID: 32407710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of a controlled human infection model of tuberculosis with aerosolised, live-attenuated Mycobacterium bovis BCG versus intradermal BCG in BCG-naive adults in the UK: a dose-escalation, randomised, controlled, phase 1 trial.
    Satti I; Marshall JL; Harris SA; Wittenberg R; Tanner R; Lopez Ramon R; Wilkie M; Ramos Lopez F; Riste M; Wright D; Peralta Alvarez MP; Williams N; Morrison H; Stylianou E; Folegatti P; Jenkin D; Vermaak S; Rask L; Cabrera Puig I; Powell Doherty R; Lawrie A; Moss P; Hinks T; Bettinson H; McShane H
    Lancet Infect Dis; 2024 Aug; 24(8):909-921. PubMed ID: 38621405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immediate delivery compared with expectant management after preterm pre-labour rupture of the membranes close to term (PPROMT trial): a randomised controlled trial.
    Morris JM; Roberts CL; Bowen JR; Patterson JA; Bond DM; Algert CS; Thornton JG; Crowther CA;
    Lancet; 2016 Jan; 387(10017):444-52. PubMed ID: 26564381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterologous immunological effects of early BCG vaccination in low-birth-weight infants in Guinea-Bissau: a randomized-controlled trial.
    Jensen KJ; Larsen N; Biering-Sørensen S; Andersen A; Eriksen HB; Monteiro I; Hougaard D; Aaby P; Netea MG; Flanagan KL; Benn CS
    J Infect Dis; 2015 Mar; 211(6):956-67. PubMed ID: 25210141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial.
    Tameris MD; Hatherill M; Landry BS; Scriba TJ; Snowden MA; Lockhart S; Shea JE; McClain JB; Hussey GD; Hanekom WA; Mahomed H; McShane H;
    Lancet; 2013 Mar; 381(9871):1021-8. PubMed ID: 23391465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune Responses Following BCG Immunization of Infants in Uganda and United Kingdom Are Similar for Purified Protein Derivative but Differ for Secretory Proteins of
    Mawa PA; Hasso-Agopsowicz M; Lubyayi L; Nabakooza G; Nakibuule M; Blitz R; Dun L; Govind A; Kaleebu P; Webb EL; Elliott AM; Dockrell HM; Cose S; Smith SG
    Front Immunol; 2021; 12():637114. PubMed ID: 33815390
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of co-trimoxazole prophylaxis on morbidity and mortality of HIV-exposed, HIV-uninfected infants in South Africa: a randomised controlled, non-inferiority trial.
    Daniels B; Coutsoudis A; Moodley-Govender E; Mulol H; Spooner E; Kiepiela P; Reddy S; Zako L; Ho NT; Kuhn L; Ramjee G
    Lancet Glob Health; 2019 Dec; 7(12):e1717-e1727. PubMed ID: 31708152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of human immunisation with a live-attenuated Mycobacterium tuberculosis vaccine: a randomised, double-blind, controlled phase I trial.
    Spertini F; Audran R; Chakour R; Karoui O; Steiner-Monard V; Thierry AC; Mayor CE; Rettby N; Jaton K; Vallotton L; Lazor-Blanchet C; Doce J; Puentes E; Marinova D; Aguilo N; Martin C
    Lancet Respir Med; 2015 Dec; 3(12):953-62. PubMed ID: 26598141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of BCG revaccination on all-cause mortality beyond infancy: 30-year follow-up of a population-based, double-blind, randomised placebo-controlled trial in Malawi.
    Glynn JR; Dube A; Fielding K; Crampin AC; ; Kanjala C; Fine PEM
    Lancet Infect Dis; 2021 Nov; 21(11):1590-1597. PubMed ID: 34237262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and immunogenicity of a protein subunit COVID-19 vaccine (ZF2001) in healthy children and adolescents aged 3-17 years in China: a randomised, double-blind, placebo-controlled, phase 1 trial and an open-label, non-randomised, non-inferiority, phase 2 trial.
    Gao L; Li Y; He P; Chen Z; Yang H; Li F; Zhang S; Wang D; Wang G; Yang S; Gong L; Ding F; Ling M; Wang X; Ci L; Dai L; Gao GF; Huang T; Hu Z; Ying Z; Sun J; Zuo X
    Lancet Child Adolesc Health; 2023 Apr; 7(4):269-279. PubMed ID: 36803632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and immunogenicity of the Vi-DT typhoid conjugate vaccine in healthy volunteers in Nepal: an observer-blind, active-controlled, randomised, non-inferiority, phase 3 trial.
    Kumar Rai G; Saluja T; Chaudhary S; Tamrakar D; Kanodia P; Giri BR; Shrestha R; Uranw S; Kim DR; Yang JS; Park IY; Kyung SE; Vemula S; Reddy E J; Kim B; Gupta BP; Jo SK; Ryu JH; Park HK; Shin JH; Lee Y; Kim H; Kim JH; Mojares ZR; Wartel TA; Sahastrabuddhe S
    Lancet Infect Dis; 2022 Apr; 22(4):529-540. PubMed ID: 34942090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.